N-[6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoyl]-L-valyl-N~5~-carbamoyl-N-[4-({[(4-nitrophenoxy)carbonyl]oxy}methyl)phenyl]-L-ornithinamide(CAS: 159857-81-5)

N-[6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoyl]-L-valyl-N~5~-carbamoyl-N-[4-({[(4-nitrophenoxy)carbonyl]oxy}methyl)phenyl]-L-ornithinamide (CAS: 159857-81-5) is a crystalline compound with a high molecular weight and excellent solubility in organic solvents. It exhibits low reactivity in most conditions but can undergo hydrolysis under basic or acidic conditions. The compound is stable in air and light. It is primarily used in pharmaceutical development.

N-[6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoyl]-L-valyl-N~5~-carbamoyl-N-[4-({[(4-nitrophenoxy)carbonyl]oxy}methyl)phenyl]-L-ornithinamide (CAS: 159857-81-5) is synthesized through a multi-step process involving peptide coupling and cyclization. Key steps include coupling the carboxylic acid with the amino group, followed by the formation of the pyrrolidine ring. The process yields a high-quality product with excellent purity.

N-[6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoyl]-L-valyl-N~5~-carbamoyl-N-[4-({[(4-nitrophenoxy)carbonyl]oxy}methyl)phenyl]-L-ornithinamide (CAS: 159857-81-5) is primarily used in the pharmaceutical industry for the development of novel drugs. It is also used in the chemical research and development sector for the synthesis of complex molecules and in the production of advanced materials.

When handling N-[6-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)hexanoyl]-L-valyl-N~5~-carbamoyl-N-[4-({[(4-nitrophenoxy)carbonyl]oxy}methyl)phenyl]-L-ornithinamide (CAS: 159857-81-5), it is crucial to wear personal protective equipment (PPE) including gloves, goggles, and a lab coat. Handle in a well-ventilated area or fume hood. Avoid inhalation and contact with skin and eyes. In case of spill, neutralize with water and dispose of according to local regulations. Refer to the Safety Data Sheet (SDS) for detailed emergency procedures.